pdufa.bio

Autologous

Updated ยทnext FDA decision on the calendar

Autologous is a BioCardia, Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

BCDA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: BioCardia, Inc. (BCDA). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026BCDA

Questions

When is Autologous's next FDA decision or readout?

The next tracked catalyst for Autologous is a Readout in Dec 2026.

What happened at Autologous's most recent FDA decision?

No FDA decision for Autologous is in our archive yet.

Who makes Autologous?

BioCardia, Inc. (BCDA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.